Seven Eight Capital »

Vaxcyte shares owned by Seven Eight Capital

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2023-03-31 $361k 9.6k 37.48
2022-12-31 $602k 13k 47.95

More positions owned by Seven Eight Capital

Edwards Lifesciences (EW)
Merck & Co (MRK)
Las Vegas Sands (LVS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertiv Holdings Com Cl A (VRT)
Intuitive Surgical Com New (ISRG)
ResMed (RMD)
Docusign (DOCU)
Fiserv (FI)
Xylem (XYL)
Meta Platforms Cl A (META)
Jabil Circuit (JBL)
Nextera Energy (NEE)

View all positions for Seven Eight Capital

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte